Session date: 
Monday, February 5, 2018 - 7:30am to 8:30am
Specialty Clinics Building; 3rd floor, Radiation Oncology C3200 Conference Room
9200 W. Wisconsin Ave
Milwaukee, WI 53226
United States
  • 1.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.00 Hours of Participation
    Hours of Participation credit.

Please login or register to take this course.
Program Description: 

This conference is intended to expose physicians to subspecialized case studies as applied to research-based-outcomes, new technologies, and treatment concepts. Each week a new topic is presented and discussed—allowing for questions and new learning developments, and conceptual enrichment.

ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA Credit Designation:
The Medical College of Wisconsin designates this Live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hours of Participation for Allied Health Professionals:
The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals.
Target audience: 
  • Radiation oncologists
  • Medical physicists
  • Radiation oncology medical and physics residents
Learning objectives: 
  • Recognize and understand the importance of the multidisciplinary approach to the care of my cancer patients.
  • Assess emerging data and technical information regarding changes and progress in the radio-therapeutic management of all forms of cancers from typical to atypical.
  • Assess the significance of new radiation approaches and technologies for the treatment of variouscancer patients based on research and clinical outcomes.
  • Determine the optimal radio-therapeutic techniques for individual cancer patients with the utilization of new technologies.  
  • Improve the quality and safety of patient radiation therapy treatments, while utilizing available tools and data and optimizing mortality rates and treatment outcomes.
  • Identify non-radiation approached to the cancer patient
  • Identify concurrent therapies to be used with radiation to achieve the best outcome for the cancer patient.
Faculty & credentials: 
Planning Committee:
Colleen Lawton, MD
Speaker: Iriana Sparks, MD "Esophogus"
All persons in control of content have NO relevant financial relationships to disclose except for:
Christopher Schultz, MDElekta, Philips, Accuray, SiemensSpeaker
Beth Erickson, MDElekta, Philips, Accuray, SiemensSpeaker
Eric Paulson, PhDElekta, Philips, Accuray, SiemensResearch/ Speaker
Jared Robbins, MDElekta, Philips, Accuray, SiemensSpeaker
William Hall, MDElekta, Philips, Accuray, SiemensResearch/ Speaker
Allen Li, PhDElekta, Philips, Accuray, SiemensResearch/ Speaker



Amanda Gross
Phone number: 
+1 (414) 805-4477